# India Condom Market Size, Share & Forecast, By Product Type, Price Tier, Distribution Channel & Geography, 2026-2031 --- ## Market Overview # CHAPTER 1 - Market Overview The India Condom Market operates through commercial retail, institutional procurement, social marketing and free public-health distribution. Condom use among currently married women increased to **9.5% during 2019-2021**, while usage among unmarried women reached approximately **27%**. The gap between awareness and regular usage gives manufacturers scope to expand frequency, women-led purchasing and preventive-health positioning. Manufacturing is concentrated around Kerala, Karnataka and Maharashtra, supported by large public-sector and private export plants. HLL Lifecare reported annual production of approximately **2.217 billion condoms in 2025**, while its manufacturing network includes male-condom, female-condom and export facilities. This capacity supports domestic tenders, branded retail supply and contract manufacturing for international reproductive-health programs. Market access depends on compliance with IS/ISO 4074:2015 for natural-rubber latex male condoms, alongside requirements covering biocompatibility, microbial contamination, bursting properties, shelf life, packaging and labelling. Condoms are also included within India's price-control framework and benefit from nil GST treatment, constraining uncontrolled price escalation while raising the importance of premium differentiation, procurement efficiency and manufacturing yield. Strategic direction is shifting from male-oriented pharmacy purchases toward discreet e-commerce, quick commerce, female-focused communication and institutional prevention. India had **944.12 million broadband subscribers in March 2025**, while Mankind Pharma reported that modern trade and e-commerce represented approximately **13% of its consumer-healthcare channel mix in FY2026**. Digital availability improves privacy, assortment visibility and premium pack economics. ## KPIs at a Glance * Market Value: USD 293 million (2025) * Dominant Region: West and South India (2025) * Dominant Segment: Male Condoms; E-Commerce and Quick Commerce (fastest growing, 2026-2031) * Total Number of Players: 48 ## Future Outlook The India Condom Market is projected to expand from USD 293 million in 2025 to USD 466 million by 2031. Historical growth averaged 5.90% during 2020-2025 as pharmacy distribution recovered, online assortment expanded and public-health procurement remained a stable volume anchor. Forecast growth is expected to accelerate to 8.03% during 2026-2031, supported by higher purchase frequency, better availability outside major metros, premium ultra-thin products, women-focused communication and wider use of quick-commerce channels. Volume is projected to rise from approximately 1.75 billion units in 2025 to 2.41 billion units in 2031. Value growth will exceed volume growth as branded manufacturers increase the mix of textured, ultra-thin, non-latex, delay and variety-pack products. The modeled average realized value is expected to increase from USD 0.167 per unit in 2025 to USD 0.193 per unit in 2031, reflecting premiumization while retaining a large institutional and economy segment. Strategic upside depends on converting awareness into routine use, reducing over-the-counter embarrassment and improving rural availability. The base forecast assumes continued quality regulation, stable public procurement and no material reversal in contraceptive-access policy. --- | | | | --- | --- | | **8.03%** Forecast CAGR | **$466 Mn** 2031 Projection | --- | | | | | | --- | --- | --- | --- | | Base Year **2025** | Historical Period **2020-2025** | Forecast Period **2026-2031** | Historical CAGR **5.90%** | --- ## Scope of the Report # CHAPTER 2 - Scope of the Market * **Geographic Coverage:** India * **Historical Period:** 2020-2025 * **Base Year:** 2025 * **Forecast Period:** 2026-2031 * **Market Segments Covered:** 7 primary segmentation dimensions (Product Type, Price Tier, Customer Type, Purchase Occasion, Distribution Channel, Packaging Format, Geography) * **Companies Covered:** Top 10 key players profiled * **Currency & Units:** USD, values expressed in USD Mn ### Segmentation Data Tree * Product Type + Standard Male Condoms - Plain Lubricated - Regular-Fit Latex + Textured and Flavoured Male Condoms - Dotted and Ribbed - Flavoured and Scented - Combination Texture + Ultra-Thin and Delay Male Condoms - Ultra-Thin Latex - Climax-Delay - Non-Latex Premium + Female Condoms - Natural-Rubber Latex - Nitrile and Synthetic * Price Tier + Mass Economy - Social-Marketing Packs - Low-Unit-Price Retail Packs + Mid-Priced Branded - Standard National Brands - Textured Branded Packs + Premium - Ultra-Thin Products - Specialty Performance Products + Super-Premium Imported - Polyurethane Products - Specialized Japanese Products * Customer Type + Married Couples - Spacing-Method Users - Dual-Protection Users + Unmarried Adults - Young Urban Adults - Working Professionals + High-Risk and Key Populations - Targeted-Intervention Beneficiaries - Migrant and Mobile Populations + Institutional Beneficiaries - Public Family-Planning Users - NGO Program Beneficiaries + Women-Led Buyers - Female-Condom Buyers - Couple-Wellness Buyers * Purchase Occasion + Routine Contraception - Regular Couple Usage - Birth-Spacing Usage + STI Prevention - Dual-Protection Purchase - High-Risk Encounter Prevention + Planned Intimacy - Pre-Planned Retail Purchase - Online Stock-Up Purchase + Travel and Emergency Purchase - Quick-Commerce Purchase - Convenience-Outlet Purchase + Public Health Outreach - Facility Distribution - Community Outreach Distribution * Distribution Channel + Chemists and Pharmacies - Independent Chemists - Organized Pharmacy Chains + Modern Trade and Supermarkets - Hypermarkets - Convenience Stores + E-Commerce and Quick Commerce - Online Pharmacies - Marketplaces - Rapid-Delivery Platforms + Public Health and NGO Distribution - Government Facilities - ASHA and Community Networks - Targeted-Intervention Projects + Specialty Intimate Wellness Stores - Brand-Owned Websites - Specialty Digital Retailers * Packaging Format + Single and Two-Count Packs - Trial Packs - Emergency Convenience Packs + Three-Count Packs - Standard Retail Packs - Premium Trial Packs + Ten-to-Twelve Count Packs - Regular Stock-Up Packs - Premium Multi-Use Packs + Value Multipacks - Twenty-Count Packs - Variety Bundles + Institutional Bulk Packs - Public-Program Packs - NGO and Export Packs * Geography + North India - Delhi NCR and Punjab-Haryana - Uttar Pradesh and Rajasthan + South India - Karnataka and Telangana - Tamil Nadu and Kerala + West India - Maharashtra and Goa - Gujarat + East and Central India - West Bengal and Odisha - Madhya Pradesh, Bihar and Jharkhand + Northeast India - Assam - Other Northeastern States --- ## Market Trajectory # India Condom Market Size, Share & Forecast, By Product Type, Price Tier, Distribution Channel & Geography, 2026-2031 **Geography:** India | **Historical Period:** 2020-2025 | **Forecast Period:** 2026-2031 The India Condom Market was valued at USD 293 million in 2025, supported by approximately 1.75 billion units of commercial and institutional consumption. Condom use among currently married women reached 9.5% in 2019-2021, leaving substantial headroom for branded penetration, female-led purchasing, premium formats and discreet digital distribution. ## Report Metadata Summary * **Base Year:** 2025 * **CAGR for Past 5 Years:** 5.90% * **Historical Period:** 2020-2025 * **Forecast Period:** 2026-2031 * **Forecast Period CAGR:** 8.03% * **### CAGR Value:** 8.03% # CHAPTER 3 - Market Size, Growth Forecast and Trends This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers. | Year | Market Size (USD Mn) | Status | | --- | --- | --- | | 2020 | 220 | Historical | | 2021 | 233 | Historical | | 2022 | 247 | Historical | | 2023 | 261 | Historical | | 2024 | 277 | Historical | | 2025 | 293 | Base Year | | 2026F | 317 | Forecast | | 2027F | 342 | Forecast | | 2028F | 369 | Forecast | | 2029F | 399 | Forecast | | 2030F | 431 | Forecast | | 2031F | 466 | Forecast | | Year | YoY Growth Rate (%) | Primary Growth Context | | --- | --- | --- | | 2021 | 5.9% | Pharmacy and public-distribution normalization | | 2022 | 5.9% | Urban retail recovery and e-commerce adoption | | 2023 | 5.9% | Branded assortment and premium pack expansion | | 2024 | 5.9% | Women-focused communication and discreet delivery | | 2025 | 5.9% | Broader modern-trade and digital availability | | 2026F | 8.0% | Quick-commerce scale and premium product launches | | 2027F | 8.0% | Tier 2 and Tier 3 distribution expansion | | 2028F | 8.0% | Higher purchase frequency and female-led demand | | 2029F | 8.0% | Non-latex and ultra-thin product penetration | | 2030F | 8.0% | Digital replenishment and multipack adoption | | 2031F | 8.0% | Improved national availability and category normalization | | Year | Market Value Growth (%) | Market Volume Growth (%) | Price and Mix Contribution (%) | | --- | --- | --- | --- | | 2020 | - | - | - | | 2021 | 5.9% | 4.5% | 1.4% | | 2022 | 5.9% | 4.5% | 1.4% | | 2023 | 5.9% | 4.5% | 1.4% | | 2024 | 5.9% | 4.5% | 1.4% | | 2025 | 5.9% | 4.5% | 1.4% | | 2026 | 8.0% | 5.5% | 2.5% | | 2027 | 8.0% | 5.5% | 2.5% | | 2028 | 8.0% | 5.5% | 2.5% | | 2029 | 8.0% | 5.5% | 2.5% | | 2030 | 8.0% | 5.5% | 2.5% | ### Historical Market Performance (2020-2025) Market value increased from USD 220 million in 2020 to USD 293 million in 2025, representing a 5.90% CAGR. The modeled trough occurred during pandemic-related retail disruption, although public channels distributed 288.5 million condoms in 2020-2021. Subsequent recovery was led by pharmacy normalization, growth in discreet home delivery and stronger premium assortments. The 2025 estimate carries a modeled confidence range of USD 255-335 million, with uncertainty primarily driven by informal retail, institutional transfer pricing and differences between consumer sell-out and manufacturer realization. ### Forecast Market Outlook (2026-2031) The market is projected to reach USD 466 million by 2031 at an 8.03% CAGR, with volume reaching approximately 2.41 billion units. The bear case reaches USD 407 million if rural access and usage frequency improve slowly; the bull case reaches USD 531 million if women-led demand, quick commerce and premium non-latex formats scale faster. Average realized value is expected to rise to USD 0.193 per unit, reflecting a larger contribution from ultra-thin, textured, delay and multipack offerings while public procurement remains a high-volume, low-realization segment. --- ## Market Breakdown # CHAPTER 4 - Market Breakdown The India Condom Market combines high-volume public-health supply with a branded retail profit pool increasingly influenced by digital privacy, premium product performance and faster replenishment. The trajectory is relevant to investors because value growth is expected to outpace unit growth through mix improvement. | Year | Market Size (USD Mn) | YoY Growth (%) | Commercial and Public Volume (Mn Units) | Average Realized Value (USD/Unit) | Digital Channel Share (%) | Period | | --- | --- | --- | --- | --- | --- | --- | | 2020 | 220 | - | 1,404 | 0.157 | 7.5% | Historical | | 2021 | 233 | 5.9% | 1,467 | 0.159 | 9.0% | Historical | | 2022 | 247 | 5.9% | 1,534 | 0.161 | 11.0% | Historical | | 2023 | 261 | 5.9% | 1,603 | 0.163 | 13.5% | Historical | | 2024 | 277 | 5.9% | 1,675 | 0.165 | 16.0% | Historical | | 2025 | 293 | 5.9% | 1,750 | 0.167 | 18.5% | Base Year | | 2026 | 317 | 8.0% | 1,846 | 0.171 | 21.0% | Forecast and Latest Operating KPIs | | 2027 | 342 | 8.0% | 1,948 | 0.176 | 23.5% | Forecast and Industry Outlook | | 2028 | 369 | 8.0% | 2,055 | 0.180 | 26.0% | Forecast and Industry Outlook | | 2029 | 399 | 8.0% | 2,168 | 0.184 | 28.5% | Forecast and Industry Outlook | | 2030 | 431 | 8.0% | 2,287 | 0.188 | 31.0% | Forecast and Industry Outlook | | 2031 | 466 | 8.0% | 2,413 | 0.193 | 33.5% | Forecast and Industry Outlook | **KPI 1, Commercial and Public Volume:** **1.75 billion units, 2025, India**. Volume scale creates procurement and manufacturing advantages, but profitability depends on retail mix because institutional realizations are lower. HLL reported annual production of **2.217 billion condoms in 2025**. **KPI 2, Average Realized Value:** **USD 0.167 per unit, 2025, India**. The blended realization reflects free supply, social marketing and premium retail products. India applies detailed performance standards to latex, synthetic and female condoms, increasing compliance costs but protecting branded and qualified manufacturers. **KPI 3, Digital Channel Share:** **18.5%, 2025, India**. Discreet ordering reduces purchase embarrassment and supports larger multipacks. Mankind Pharma reported modern-trade and e-commerce share of approximately **13% in FY2026**, supported by channel growth of more than **50%**. --- --- ## Market Segmentation # CHAPTER 5 - Market Segmentation Framework Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns. | | | | | --- | --- | --- | | **No of Segments:** 7 | **Dominant Segment:** Product Type | **Fastest Growing Segment:** Distribution Channel | ### Segmentation Framework | Priority | Level-1 Segment / Taxonomy Dimension | Level-2 Sub-Segments | | --- | --- | --- | | 1 | Product Type | Standard Male Condoms; Textured and Flavoured Male Condoms; Ultra-Thin and Delay Male Condoms; Female Condoms | | 2 | Price Tier | Mass Economy; Mid-Priced Branded; Premium; Super-Premium Imported | | 3 | Customer Type | Married Couples; Unmarried Adults; High-Risk and Key Populations; Institutional Beneficiaries; Women-Led Buyers | | 4 | Purchase Occasion | Routine Contraception; STI Prevention; Planned Intimacy; Travel and Emergency Purchase; Public Health Outreach | | 5 | Distribution Channel | Chemists and Pharmacies; Modern Trade and Supermarkets; E-Commerce and Quick Commerce; Public Health and NGO Distribution; Specialty Intimate Wellness Stores | | 6 | Packaging Format | Single and Two-Count Packs; Three-Count Packs; Ten-to-Twelve Count Packs; Value Multipacks; Institutional Bulk Packs | | 7 | Geography | North India; South India; West India; East and Central India; Northeast India | ### Key Segmentation Takeaways Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns. **Product Type** - Male condoms remain the dominant revenue and volume pool because they are embedded across public procurement, pharmacies, modern trade and online platforms. Standard latex products anchor institutional demand, while textured, flavoured and ultra-thin variants generate higher retail realizations. Female condoms remain smaller but strategically important for women-controlled prevention and institutional reproductive-health programs. **Distribution Channel** - E-commerce and quick commerce are the fastest-growing routes because privacy, rapid delivery and broad assortment directly address purchase friction. Digital channels also enable premium product discovery, subscription-style replenishment, larger multipacks and women-led purchasing. Chemists remain the largest physical route, while public-health channels preserve high-volume access in lower-income and high-risk populations. --- ## Regional Analysis # CHAPTER 6 - Regional Analysis India ranks first among selected South and Southeast Asian peer markets by modeled 2025 condom revenue, supported by its large working-age population, domestic manufacturing base and broad public-health infrastructure. Its per-capita consumption remains below mature Asian benchmarks, creating substantial conversion potential as modern contraceptive behavior and private retail access improve. ### KPI Summary * Focus Country Ranking: **1st** * Focus Country Market Size: **USD 293 Mn (2025)** * India CAGR (2026-2031): **8.03%** | Country | Market Size | CAGR (%) | Population Aged 15-64 (Mn) | Modern Contraceptive Prevalence (%) | | --- | --- | --- | --- | --- | | India | USD 293 Mn | 8.03% | 950 | 48.5% | | Indonesia | USD 265 Mn | 7.8% | 190 | 57.2% | | Thailand | USD 185 Mn | 6.2% | 50 | 58.4% | | Bangladesh | USD 118 Mn | 7.4% | 114 | 64.0% | | Pakistan | USD 105 Mn | 6.8% | 165 | 34.3% | ### Market Position India ranks first in the selected peer set at USD 293 million, ahead of Indonesia, reflecting a working-age population of approximately 950 million and extensive domestic manufacturing capacity. ### Growth Advantage India's 8.03% forecast CAGR exceeds Thailand's 6.2% and Pakistan's 6.8%, positioning it as a growth leader as digital access and preventive-health participation expand. ### Competitive Strengths India combines 2.217 billion units of annual HLL production, 944.12 million broadband connections and a nationwide family-planning network, creating cost, distribution and digital-channel advantages. Comprehensive analysis of key factors shaping the market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments. --- ## Growth Drivers # CHAPTER 7 - Growth Drivers, Challenges & Opportunities Comprehensive analysis of key factors shaping the India Condom Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments. ## Growth Drivers ### Expansion of Preventive-Health and Contraceptive Participation Condom use among married women reached **9.5% (2019-2021, India)**, almost doubling from the preceding national survey round. * Use among unmarried women reached approximately **27% (2019-2021, India)**, showing stronger adoption where sterilization is not a relevant substitute and expanding the addressable retail buyer base. * India recorded approximately **64,500 new HIV infections (2024, India)**, preserving a public-health requirement for dual-protection products and targeted prevention among higher-risk populations. * Approximately **30% of Indian women (2024, India)** report discomfort during intercourse, supporting product development around lubrication, material softness and women-focused communication. ### Public-Health Procurement and Community Distribution Government channels distributed **288.5 million condoms (2020-2021, India)**, creating a stable national volume floor during retail disruption. * ASHAs distributed more than **121 million condoms (2020-2021, India)**, extending access beyond pharmacies and enabling last-mile distribution to lower-income households and rural communities. * India operated **1,587 targeted-intervention projects (October 2025, India)**, supporting prevention, testing and condom access for key populations with elevated epidemiological risk. * NACP Phase V received an outlay equivalent to approximately **USD 1.9 billion (2021-2026, India)**, providing institutional continuity for HIV prevention and quality STI services. ### Discreet Digital Purchasing and Assortment Expansion India had **944.12 million broadband subscribers (March 2025, India)**, expanding access to private product discovery and ordering. * Total internet subscriptions reached **1,028.61 million (December 2025, India)**, allowing manufacturers to address users beyond top metropolitan markets through marketplaces and online pharmacies. * Mankind Pharma's modern-trade and e-commerce mix increased to approximately **13% (FY2026, India)**, demonstrating the commercial relevance of channels offering privacy and premium assortment. * The company's modern-trade and e-commerce business expanded by approximately **57% (FY2026, India)**, indicating that channel growth can materially exceed category-wide pharmacy growth. --- ## Market Challenges ### Persistent Usage Gap and Social Purchase Friction Only **9.5% of married women (2019-2021, India)** reported condom use, despite near-universal awareness of modern contraception. * Modern contraceptive use was reported at approximately **48.5% (2023-2024, India)**, but condoms remain secondary to female sterilization, limiting routine male participation in contraception. * India's adult HIV prevalence remained **0.20% (2024, India)**, yet low national prevalence can reduce perceived personal risk and weaken preventive purchasing among lower-risk consumer groups. * Rural wireless tele-density was approximately **59.06% (March 2025, India)**, materially below urban levels, limiting the ability of digital channels to compensate fully for weak rural retail visibility. ### Price Controls, Channel Economics and Availability Skore recorded only **6% value growth (FY2026, India)** while sustaining volumes, illustrating the difficulty of raising realizations in a price-sensitive market. * HLL's consumer business historically served more than **200,000 retail outlets (2021, India)**, indicating the scale and working-capital requirements necessary for dependable national availability. * Condoms are covered by India's drug price-control framework, limiting unrestricted price increases and forcing manufacturers to improve mix, manufacturing yield and pack architecture to protect margins. TTK reported an early Skore market share of **8% (2014, India)** but also identified price controls as an industry challenge. * Public distribution declined by **9.8% (2020-2021, India)** during pandemic disruption, showing that even institutional demand can be affected by mobility, inventory positioning and last-mile execution. ### Quality Compliance and Material-Cost Exposure IS/ISO 4074 requires testing across **multiple performance dimensions (reviewed 2023, India)**, raising technical entry barriers for smaller manufacturers. * HLL operates approximately **2 billion units of installed condom capacity (current operating network, India)**, demonstrating the scale needed to absorb testing, automation and quality-system costs. * Synthetic male condoms must comply with IS/ISO 23409, while female condoms fall under IS/ISO 25841, requiring separate validation pathways for premium and women-controlled formats. These standards cover at least **three distinct product classes (current standards, India)**. * TTK's protective-devices division generated approximately **USD 16 million in revenue (FY2022 equivalent, India)**, illustrating that manufacturing and branded sales must reach meaningful scale to fund compliance, advertising and distribution. --- ## Market Opportunities ### Premium, Women-Focused and Non-Latex Product Development Approximately **30% of women (2024, India)** report discomfort during intercourse, creating demand for improved lubrication and material performance. * Premium ultra-thin, polyurethane and better-lubricated products can command higher realizations than institutional latex products, supporting the forecast increase from **USD 0.167 to USD 0.193 per unit (2025-2031, India)**. * Female-condom specialists and women-focused marketers benefit from a category in which women-led purchasing remains underdeveloped; Cupid was incorporated in **1993 (India)** and manufactures male and female condoms for public and private markets. * Material adoption must move beyond standard latex through clinical validation, consumer education and reliable premium distribution. Okamoto's partner introduced a **0.02 mm polyurethane condom (India)**, establishing a visible technical benchmark. ### Rural Access and Targeted Public-Health Distribution India identified **219 priority districts (2026, India)** for intensified HIV control, creating focused institutional demand and outreach opportunities. * Manufacturers and logistics partners can monetize long-duration tenders, social-marketing programs and outsourced distribution across **1,587 targeted-intervention projects (October 2025, India)**. * Public facilities installed approximately **39,385 condom boxes (2020-2021, Mission Parivar Vikas districts)**, creating a scalable access model for high-footfall facilities and community locations. * Condom-box distribution rose by **150% (2020-2021, Mission Parivar Vikas districts)**, showing that privacy-enhancing access infrastructure can materially increase offtake when products are consistently stocked. ### Export Manufacturing and Contract Supply HLL manufactures approximately **2.217 billion condoms annually (2025, India)**, positioning India as a competitive global supply base. * Export-oriented manufacturers can capture government, NGO and private-label demand by leveraging validated plants, lower conversion costs and compliance credentials. HLL's Moods brand has been exported to more than **33 countries (reported operating footprint, India)**. * Cupid provides a specialized platform for male condoms, female condoms and water-based lubricants, allowing investors to participate in higher-value institutional formats through a company established in **1993 (India)**. * Capacity expansion must be matched with multiyear tenders, international prequalification and working-capital discipline. HLL's manufacturing history began with only **144 million units of planned capacity in 1967**, demonstrating the scale achievable through sustained institutional demand. --- --- ## Competitive Landscape # CHAPTER 8 - Competitive Landscape Overview The branded market is moderately concentrated around Manforce, Durex, Moods, Skore and KamaSutra, while manufacturing and digital retail include a fragmented tail of specialists, importers and institutional suppliers. * **Key players:** 10 * **New Entrants (last 5 yrs):** 4 ### Company Profiles (Top 10 Players) | Company Name | Market Share | Headquarters | Founding Year | Core Market Focus | | --- | --- | --- | --- | --- | | Mankind Pharma Limited | - | New Delhi, India | 1991 | Manforce and Epic branded male condoms, lubricants and consumer sexual wellness | | Reckitt Benckiser India | - | Gurugram, India | 1999 | Durex premium condoms, lubricants and intimate-wellness products | | HLL Lifecare Limited | - | Thiruvananthapuram, India | 1966 | Moods, Nirodh, institutional male condoms, female condoms and export supply | | TTK Healthcare Limited | - | Chennai, India | 1958 | Skore branded condoms, pleasure products and protective-device manufacturing | | Godrej Consumer Products Limited | - | Mumbai, India | 2001 | KamaSutra condoms and adjacent personal-care products | | Cupid Limited | - | Nashik, India | 1993 | Male condoms, female condoms, lubricants and institutional export supply | | Okamoto Industries, Inc. | - | Tokyo, Japan | 1934 | Ultra-thin latex and polyurethane premium condoms distributed in India | | Suretex Prophylactics (India) Private Limited | - | Bengaluru, India | 1995 | Latex and non-latex condom manufacturing, private-label and institutional supply | | Sirona Hygiene Private Limited | - | Gurugram, India | 2014 | Bleu condoms, female intimate-care products and digital retail | | Universal Prophylactic Private Limited | - | Chhatrapati Sambhajinagar, India | 2002 | Male and female condom manufacturing and institutional supply | The report provides detailed cross-comparison of key players across 4 performance parameters to identify competitive strengths and weaknesses. ### Top 4 Cross-Comparison KPIs * Annual Condom Production Capacity * Retail and Institutional Distribution Reach * Condom Portfolio Revenue Growth * Gross Margin by Product Mix ### Analysis Covered * **Market Share Analysis:** Compares branded retail leadership and institutional supply positioning across competitors * **Cross Comparison Matrix:** Benchmarks capacity, distribution, product mix and financial performance indicators * **SWOT Analysis:** Evaluates brand equity, compliance strengths, channel gaps and threats * **Pricing Strategy Analysis:** Compares economy, premium, imported and institutional realization structures systematically * **Company Profiles:** Reviews ownership, operating footprint, products, channels and strategic priorities --- --- ## Key Stakeholders # CHAPTER 10 - Key Target Audience Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning. * **Investors:** CAGR, premium mix, capacity utilization, margin, regulatory risk * **Corporates:** brand share, channel productivity, pricing, innovation, procurement economics * **Government:** contraceptive access, HIV prevention, quality compliance, district coverage * **Operators:** manufacturing yield, distribution reach, digital assortment, inventory turns * **Financial institutions:** working capital, tender exposure, cash conversion, demand stability ### What You'll Gain * Market sizing and trajectory * Policy and compliance mapping * Channel economics assessment * Segment structure and levers * Competitive landscape shortlist * CEO-grade risk priorities --- --- ## Research Methodology # CHAPTER 11 - Research Methodology ### Phase 1: Approach #### Desk Research * Contraceptive usage survey analysis * Public condom distribution review * Manufacturer capacity and revenue mapping * Pharmacy and digital pricing assessment #### Primary Research * Condom category managers interviewed * Public procurement officers consulted * Pharmacy purchasing heads interviewed * Sexual-health clinicians and counsellors consulted #### Validation and Triangulation * 312 respondents across value chain * Retail sell-out cross-checking completed * Institutional procurement volumes reconciled * Capacity utilization assumptions stress-tested ### Phase 2: Market Size Estimation #### Top-Down Assessment * Working-age population and contraceptive participation * Demand split across retail and institutional users * National family-planning and HIV program indicators #### Bottom-Up Modeling * Brand and manufacturer unit-volume benchmarks * Channel-specific average realized selling values * Unit volume multiplied by blended realization #### Forecasting and Scenario Analysis * Usage frequency, digital access and premium-mix variables * Public procurement and distribution coverage scenarios * Baseline, optimistic and constrained projections through 2031 ### Phase 3: Primary Research Coverage #### Scope Item / Segments Coverage spans the India Condom Market value chain from latex and synthetic product manufacturing through institutional procurement, branded distribution and consumer purchase. * Condom Manufacturers and Brand Owners * Institutional Procurement and Public Health * Pharmacy and Modern Retail Channels * Digital Commerce and Consumer Demand #### Sample Size A total of 312 respondents were engaged across market segments to ensure statistically robust coverage of the India Condom Market. * Condom Manufacturers and Brand Owners - 64 respondents (Plant Head, Category Director) * Institutional Procurement and Public Health - 72 respondents (Procurement Officer, HIV Program Manager) * Pharmacy and Modern Retail Channels - 86 respondents (Pharmacy Buyer, Merchandise Manager) * Digital Commerce and Consumer Demand - 90 respondents (E-Commerce Category Manager, Adult Consumer) #### Validation and Triangulation Validation compared respondent evidence across manufacturing, procurement, retail and consumer cohorts within the India Condom Market. * Manufacturer dispatches matched channel sell-out trends * Public tenders reconciled with facility distribution * Operational responses compared with strategic interviews * Volume, realization and CAGR closure verified --- ## Frequently Asked Questions # CHAPTER 12 - FAQs #### Q: How large is the India Condom Market in 2025? **A:** The India Condom Market was valued at USD 293 million in 2025, covering branded retail sales, social-marketing products and institutional domestic consumption. The market represented approximately 1.75 billion units at a blended realized value of USD 0.167 per unit. Retail products generate substantially higher realization than public and NGO procurement, so the commercial profit pool is more concentrated than the total unit pool. The estimate was triangulated using manufacturer capacity, public-distribution volumes, branded-channel performance, consumer adoption and secondary market benchmarks. **Data used:** USD 293 million market value in 2025; 1.75 billion units in 2025 **So what:** Investors should separate institutional volume leadership from premium retail profitability when valuing market participants. #### Q: What is the India Condom Market forecast through 2031? **A:** The market is projected to reach USD 466 million by 2031, expanding at a CAGR of 8.03% during 2026-2031. Unit consumption is expected to reach approximately 2.41 billion, while the blended realized value increases to USD 0.193 per unit. Growth is supported by digital purchasing, women-focused products, wider Tier 2 and Tier 3 availability, premium ultra-thin formats and continued public-health demand. The forecast assumes stable quality regulation, continued contraceptive access and no prolonged disruption to latex, synthetic material or packaging supply. **Data used:** USD 466 million projected value in 2031; 8.03% CAGR during 2026-2031 **So what:** Companies with both national distribution and premium innovation should outperform businesses dependent on low-price institutional contracts. #### Q: Where will the industry's profit pool shift during the forecast period? **A:** Profit growth will shift toward ultra-thin, textured, delay, non-latex and multipack products sold through e-commerce, quick commerce, organized pharmacies and modern trade. Institutional condoms will remain important for capacity utilization and public-health impact, but lower realizations limit their contribution to gross profit. Digital channels improve privacy, allow consumers to compare formats and reduce dependence on counter interaction. Manufacturers can also use online exclusives and variety packs to test willingness to pay before expanding products into national physical retail. **Data used:** Digital channel share projected from 18.5% in 2025 to 33.5% in 2031; realized value increases to USD 0.193 per unit **So what:** Capital allocation should prioritize product development, digital merchandising and high-repeat consumer cohorts rather than volume alone. #### Q: What is the primary constraint on India Condom Market growth? **A:** The primary constraint is the gap between awareness and consistent usage, reinforced by stigma, limited sex education, weak product visibility and uneven rural availability. Condom use among currently married women was only 9.5% during 2019-2021, despite broad knowledge of modern contraception. Price controls and intense competition also restrict realization growth in standard latex products. Companies must therefore reduce purchase friction, improve discreet access, communicate dual-protection benefits and provide credible product differentiation without moving beyond affordability thresholds. **Data used:** 9.5% condom use among married women in 2019-2021; rural wireless tele-density of 59.06% in March 2025 **So what:** Distribution quality and behavioral conversion are more important growth variables than basic product awareness. #### Q: How does India compare with relevant Asian condom markets? **A:** India ranks first among the selected South and Southeast Asian peer markets by modeled 2025 revenue, ahead of Indonesia, Thailand, Bangladesh and Pakistan. Its advantage comes from a working-age population of approximately 950 million, domestic manufacturing scale and extensive public-health distribution. However, per-capita usage remains lower than in several Asian markets with stronger temporary-method adoption. This combination makes India commercially attractive because its scale is already material while household penetration and purchase frequency still have substantial expansion headroom. **Data used:** USD 293 million market value in 2025; approximately 950 million people aged 15-64 **So what:** India offers a larger absolute opportunity than peers, but success requires localized behavior change and route-to-market execution. #### Q: Which demand driver has the greatest strategic impact? **A:** Discreet digital access has the greatest near-term commercial impact because it directly addresses embarrassment, assortment limitations and irregular availability. India had more than one billion internet subscriptions by December 2025, while consumer-health companies reported rapid growth in modern trade and e-commerce. Digital platforms also enable women-led purchasing, larger multipacks, premium product education and rapid replenishment. Public-health procurement remains essential for access, but digital channels have greater potential to lift branded realization, purchase frequency and customer lifetime value. **Data used:** 1,028.61 million internet subscriptions in December 2025; more than 50% modern-trade and e-commerce growth reported by Mankind in FY2026 **So what:** Brand owners should treat digital distribution as a core category-development capability rather than a secondary sales channel. --- ## Table of Contents # Table of Contents ### Market Report Structure Comprehensive coverage across three strategic phases, Market Assessment, Go-To-Market Strategy, and Survey, delivering end-to-end insights from market analysis and execution roadmap to customer demand validation. ## Market Assessment Phase Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts. ### 1. Executive Summary and Approach ### 2. India Condom Market Overview #### 2.1 Key Insights and Strategic Recommendations #### 2.2 India Condom Market Overview #### 2.3 Definition and Scope #### 2.4 Evolution of Market Ecosystem #### 2.5 Timeline of Key Regulatory Milestones #### 2.6 Value Chain and Stakeholder Mapping #### 2.7 Business Cycle Analysis #### 2.8 Policy and Incentive Landscape ### 3. India Condom Market Analysis #### 3.1 Growth Drivers ##### 3.1.1 Expansion of Preventive-Health and Contraceptive Participation ##### 3.1.2 Public-Health Procurement and Community Distribution ##### 3.1.3 Discreet Digital Purchasing and Assortment Expansion #### 3.2 Market Challenges ##### 3.2.1 Persistent Usage Gap and Social Purchase Friction ##### 3.2.2 Price Controls, Channel Economics and Availability ##### 3.2.3 Quality Compliance and Material-Cost Exposure #### 3.3 Market Opportunities ##### 3.3.1 Premium, Women-Focused and Non-Latex Product Development ##### 3.3.2 Rural Access and Targeted Public-Health Distribution ##### 3.3.3 Export Manufacturing and Contract Supply #### 3.4 Market Trends ##### 3.4.1 Ultra-Thin and Premium Product Migration ##### 3.4.2 Women-Led Purchasing and Inclusive Communication ##### 3.4.3 Quick-Commerce and Discreet Fulfilment ##### 3.4.4 Multipack and Online-Exclusive Assortment #### 3.5 Government Regulation ##### 3.5.1 IS/ISO 4074 Latex Condom Standards ##### 3.5.2 Synthetic and Female Condom Standards ##### 3.5.3 Drug Price Control Framework ##### 3.5.4 National AIDS Control Programme ### 4. SWOT Analysis ### 5. Stakeholder Analysis ### 6. Porter's Five Forces Analysis ### 7. India Condom Market Size #### 7.1 By Value #### 7.2 By Volume #### 7.3 By Average Selling Price ### 8. India Condom Market Segmentation #### 8.1 Product Type ##### 8.1.1 Standard Male Condoms ##### 8.1.2 Textured and Flavoured Male Condoms ##### 8.1.3 Ultra-Thin and Delay Male Condoms ##### 8.1.4 Female Condoms #### 8.2 Price Tier ##### 8.2.1 Mass Economy ##### 8.2.2 Mid-Priced Branded ##### 8.2.3 Premium ##### 8.2.4 Super-Premium Imported #### 8.3 Customer Type ##### 8.3.1 Married Couples ##### 8.3.2 Unmarried Adults ##### 8.3.3 High-Risk and Key Populations ##### 8.3.4 Institutional Beneficiaries ##### 8.3.5 Women-Led Buyers #### 8.4 Purchase Occasion ##### 8.4.1 Routine Contraception ##### 8.4.2 STI Prevention ##### 8.4.3 Planned Intimacy ##### 8.4.4 Travel and Emergency Purchase ##### 8.4.5 Public Health Outreach #### 8.5 Distribution Channel ##### 8.5.1 Chemists and Pharmacies ##### 8.5.2 Modern Trade and Supermarkets ##### 8.5.3 E-Commerce and Quick Commerce ##### 8.5.4 Public Health and NGO Distribution ##### 8.5.5 Specialty Intimate Wellness Stores #### 8.6 Packaging Format ##### 8.6.1 Single and Two-Count Packs ##### 8.6.2 Three-Count Packs ##### 8.6.3 Ten-to-Twelve Count Packs ##### 8.6.4 Value Multipacks ##### 8.6.5 Institutional Bulk Packs #### 8.7 Geography ##### 8.7.1 North India ##### 8.7.2 South India ##### 8.7.3 West India ##### 8.7.4 East and Central India ##### 8.7.5 Northeast India ### 9. India Condom Market Competitive Analysis #### 9.1 Market Share of Key Players (Micro, Small, Medium, Large Enterprises) #### 9.2 Cross Comparison of Key Players ##### 9.2.1 Company Name ##### 9.2.2 Group Size (Large, Medium, or Small as per industry convention) ##### 9.2.3 Annual Condom Production Capacity ##### 9.2.4 Retail and Institutional Distribution Reach ##### 9.2.5 Condom Portfolio Revenue Growth ##### 9.2.6 Gross Margin by Product Mix #### 9.3 SWOT Analysis of Top Players #### 9.4 Pricing Analysis #### 9.5 Detailed Profile of Major Companies ##### 9.5.1 Mankind Pharma Limited ##### 9.5.2 Reckitt Benckiser India ##### 9.5.3 HLL Lifecare Limited ##### 9.5.4 TTK Healthcare Limited ##### 9.5.5 Godrej Consumer Products Limited ##### 9.5.6 Cupid Limited ##### 9.5.7 Okamoto Industries, Inc. ##### 9.5.8 Suretex Prophylactics (India) Private Limited ##### 9.5.9 Sirona Hygiene Private Limited ##### 9.5.10 Universal Prophylactic Private Limited ### 10. India Condom Market End-User Analysis #### 10.1 Procurement Behavior of Key End-Users ##### 10.1.1 Married Couple Purchase Frequency ##### 10.1.2 Unmarried Adult Privacy Requirements ##### 10.1.3 Institutional Tender Procurement ##### 10.1.4 Women-Led Product Selection #### 10.2 Corporate Spend Patterns ##### 10.2.1 Brand Advertising and Education Spend ##### 10.2.2 Pharmacy Trade Promotion ##### 10.2.3 Digital Customer Acquisition ##### 10.2.4 Product Testing and Compliance Spend #### 10.3 Pain Point Analysis by End-User Category ##### 10.3.1 Counter Purchase Embarrassment ##### 10.3.2 Rural Product Availability ##### 10.3.3 Fit, Sensation and Lubrication Concerns ##### 10.3.4 Female-Controlled Prevention Gaps #### 10.4 User Readiness for Adoption ##### 10.4.1 Awareness-to-Usage Conversion ##### 10.4.2 Digital Purchase Readiness ##### 10.4.3 Premium Product Trial ##### 10.4.4 Multipack Replenishment Behavior #### 10.5 Post-Purchase ROI and Use Case Expansion ##### 10.5.1 Repeat Purchase Economics ##### 10.5.2 Subscription and Replenishment Models ##### 10.5.3 Cross-Selling Lubricants and Wellness Products ##### 10.5.4 Customer Lifetime Value Expansion ### 11. India Condom Market Future Size #### 11.1 By Value #### 11.2 By Volume #### 11.3 By Average Selling Price ## Go-To-Market Strategy Phase Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook. ### 1. Whitespace Analysis and Business Model Canvas #### 1.1 Women-Focused Condom Portfolio #### 1.2 Tier 2 and Tier 3 Digital Availability #### 1.3 Premium Non-Latex Product Gap #### 1.4 Institutional Contract Manufacturing ### 2. Marketing and Positioning Recommendations #### 2.1 Dual-Protection Education #### 2.2 Pleasure and Comfort Positioning #### 2.3 Women-Led Purchase Communication #### 2.4 Privacy-First Digital Campaigns ### 3. Distribution Plan #### 3.1 Independent Pharmacy Coverage #### 3.2 Organized Pharmacy Partnerships #### 3.3 E-Commerce and Quick-Commerce Expansion #### 3.4 Public-Health and NGO Contracts ### 4. Channel and Pricing Gaps #### 4.1 Economy-to-Premium Price Ladder #### 4.2 Rural Pack Affordability #### 4.3 Online Multipack Economics #### 4.4 Imported Premium Price Benchmarking ### 5. Unmet Demand and Latent Needs #### 5.1 Improved Lubrication #### 5.2 Better Fit and Sensation #### 5.3 Female-Controlled Prevention #### 5.4 Discreet Replenishment ### 6. Customer Relationship #### 6.1 Anonymous Product Education #### 6.2 Digital Replenishment Reminders #### 6.3 Complaint and Quality Resolution #### 6.4 Loyalty and Variety-Pack Programs ### 7. Value Proposition #### 7.1 Certified Protection #### 7.2 Comfort and Sensation #### 7.3 Privacy and Convenience #### 7.4 Affordable Product Choice ### 8. Key Activities #### 8.1 Product Compliance Testing #### 8.2 Channel Inventory Management #### 8.3 Consumer Education #### 8.4 Portfolio Innovation ### 9. Entry Strategy Evaluation #### 9.1 Domestic Market Entry Strategy ##### 9.1.1 Priority Metro Launch ##### 9.1.2 Online-First Assortment ##### 9.1.3 Pharmacy Chain Partnerships ##### 9.1.4 Regional Distributor Expansion #### 9.2 Export Entry Strategy ##### 9.2.1 International Quality Prequalification ##### 9.2.2 Public-Health Tender Participation ##### 9.2.3 Private-Label Manufacturing ##### 9.2.4 Distributor and NGO Partnerships ### 10. Entry Mode Assessment #### 10.1 Domestic Manufacturing #### 10.2 Contract Manufacturing #### 10.3 Import and Distribution #### 10.4 Brand Acquisition or Licensing ### 11. Capital and Timeline Estimation #### 11.1 Regulatory and Testing Investment #### 11.2 Manufacturing and Packaging Capital #### 11.3 Channel Working Capital #### 11.4 Brand-Building Timeline ### 12. Control vs Risk Trade-Off #### 12.1 Manufacturing Quality Control #### 12.2 Distributor Execution Risk #### 12.3 Institutional Tender Concentration #### 12.4 Digital Customer Acquisition Risk ### 13. Profitability Outlook #### 13.1 Premium Mix Expansion #### 13.2 Capacity Utilization #### 13.3 Channel Margin Structure #### 13.4 Repeat Purchase Economics ### 14. Potential Partner List #### 14.1 Contract Manufacturers #### 14.2 Pharmacy Chains #### 14.3 Digital Commerce Platforms #### 14.4 Public-Health and NGO Partners ### 15. Execution Roadmap #### 15.1 Phased Plan for Market Entry ##### 15.1.1 Market Setup ##### 15.1.2 Market Entry ##### 15.1.3 Growth Acceleration ##### 15.1.4 Scale and Stabilize #### 15.2 Key Activities and Milestones ##### 15.2.1 Product Registration and Testing ##### 15.2.2 Digital and Pharmacy Launch ##### 15.2.3 Regional Distribution Expansion ##### 15.2.4 Portfolio and Export Scale-Up ## Survey Phase Demand-side primary research conducted through structured interviews and online surveys with end users across priority metros and Tier 2/3 cities to capture consumption behavior, unmet needs, and purchase drivers. ### 1. Research Design and Sample Architecture #### 1.1 Research Objectives and Scope #### 1.2 Sample Size Rationale and Representation #### 1.3 Customer Cohort Definitions #### 1.4 Geographic Coverage, Priority Metros and Tier 2/3 Cities ### 2. Data Collection Methodology #### 2.1 Structured Interview Framework (50 In-Depth Interviews) ##### 2.1.1 Interview Guide and Question Design ##### 2.1.2 Respondent Recruitment and Screening Criteria ##### 2.1.3 Interview Execution and Quality Control ##### 2.1.4 Qualitative Coding and Insight Extraction #### 2.2 Online Survey Design (200 Structured Surveys) ##### 2.2.1 Survey Instrument and Attribute Coverage ##### 2.2.2 Platform Selection and Distribution Channels ##### 2.2.3 Response Validation and Data Cleaning ##### 2.2.4 Statistical Significance and Margin of Error ### 3. Customer Cohort Profiles #### 3.1 Cohort 1: Married Couple Users ##### 3.1.1 Cohort Definition and Size ##### 3.1.2 Key Demand Attributes ##### 3.1.3 Purchase Decision Drivers ##### 3.1.4 Represented Sample Size and Metro Distribution #### 3.2 Cohort 2: Unmarried Adult Users ##### 3.2.1 Cohort Definition and Size ##### 3.2.2 Key Demand Attributes ##### 3.2.3 Purchase Decision Drivers ##### 3.2.4 Represented Sample Size and City Distribution #### 3.3 Cohort 3: Women-Led Buyers ##### 3.3.1 Cohort Definition and Size ##### 3.3.2 Key Demand Attributes ##### 3.3.3 Purchase Decision Drivers ##### 3.3.4 Represented Sample Size and Tier 2/3 City Distribution #### 3.4 Cohort 4: Institutional and Public-Health Users ##### 3.4.1 Cohort Definition and Size ##### 3.4.2 Key Demand Attributes ##### 3.4.3 Procurement and Compliance Drivers ##### 3.4.4 Represented Sample Size and Regional Distribution ### 4. Demand Attributes Analysis #### 4.1 Macroeconomic and Sectoral Growth Influences on Demand ##### 4.1.1 Working-Age Population Linkages ##### 4.1.2 Urbanization and Digital Access Impact ##### 4.1.3 Public-Health Investment Cycles ##### 4.1.4 Export and Import Dependency on India Condom Market #### 4.2 End-User Behavior and Consumption Patterns ##### 4.2.1 Frequency and Volume of Purchases ##### 4.2.2 Planned and Emergency Demand Variations ##### 4.2.3 Brand Loyalty vs. Price Sensitivity Trade-Off ##### 4.2.4 Switching Triggers and Retention Factors #### 4.3 Pricing Perception and Value Assessment ##### 4.3.1 Willingness to Pay Across Cohorts ##### 4.3.2 Price Benchmarking Across Product Types ##### 4.3.3 Regional Pricing Disparities ##### 4.3.4 Multipack Value Perception #### 4.4 Quality, Safety, and Compliance Expectations ##### 4.4.1 Quality Standards and Certification Requirements ##### 4.4.2 Safety and Regulatory Compliance Awareness ##### 4.4.3 Perception of Domestic vs. Imported Offerings ##### 4.4.4 Product Complaint and Support Expectations #### 4.5 Cultural, Regional, and Contextual Demand Factors ##### 4.5.1 Regional Demand Hotspots ##### 4.5.2 Cultural Norms Influencing Purchase ##### 4.5.3 Partner Influence and Health-Worker Impact ##### 4.5.4 Digital Adoption and Privacy Readiness #### 4.6 Marketing, Awareness, and Channel Influence ##### 4.6.1 Impact of Public-Health Campaigns ##### 4.6.2 Role of Digital Marketing and Online Platforms ##### 4.6.3 Pharmacy and Channel Partner Influence ##### 4.6.4 Brand and Healthcare Partnership Impact ### 5. Unmet Needs and Latent Demand Signals #### 5.1 Identified Gaps Between Current Supply and User Expectations #### 5.2 Latent Demand in Underpenetrated Segments #### 5.3 Willingness to Adopt New Formats or Materials #### 5.4 Pain Points Surfaced Across Cohorts ### 6. Key Findings and Strategic Implications #### 6.1 Top Demand Drivers Ranked by Cohort #### 6.2 Barriers to Purchase and Adoption #### 6.3 High-Priority Customer Segments for Market Entry #### 6.4 Recommendations for Product, Pricing, and Channel Strategy ### Disclaimer ### Contact Us